In The News Posted May 14, 2020 Share Posted May 14, 2020 ABBOTT PARK, Ill., May 14, 2020 /PRNewswire/ -- (NYSE: ABT) -- Abbott's ID NOW™ is the fastest molecular point-of-care rapid test available today and has been delivering reliable results when and where they're needed. The availability and ease-of-access of ID NOW, which delivers results...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.